FDA Approves Moderna’s Lower-Dose COVID-19 Vaccine
Moderna has received FDA approval for a new lower-dose COVID-19 vaccine, with restrictions on who can use it. The vaccine, mNexspike, is designed to be one-fifth the dose of its current vaccine, Spikevax. It will be available to adults 65 and older, and people aged 12-64 with certain health conditions. The FDA’s approval is based … Read more